EUVIMEDEUVIMED entdecken
Crossref

Serotonergic Antidepressant Use and Risk of Clinically Significant Bleeding in Thrombocytopenic Hematologic Malignancy Patients

Hannah Delp iD, Marissa Olson, Emily Owen, Colleen McEvoy, Emily Gill iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251319757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Hannah Delp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Thrombocytopenia, Hematologic Neoplasms, Hemorrhage, Selective Serotonin Reuptake Inhibitors. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serotonin reuptake inhibitor (SRI) antidepressants have known antiplatelet properties. Patients with hematologic malignancies (HMs) are at an increased risk of bleeding complications due to their malignancy and treatment-induced thrombocytopenia.

Objective

The purpose of this study was to evaluate the risk of clinically significant bleeding (CSB) in patients with HM and thrombocytopenia who are prescribed SRIs.

Methods

This retrospective cohort study included adult patients admitted to the hospital with HM and thrombocytopenia. Patients were stratified into SRI-exposed and SRI-unexposed groups. Patients were followed up until resolution of thrombocytopenia, hospital discharge, death, or SRI therapy interruption. The primary outcome was the incidence of CSB.

Results

A total of the 324 patients were included in the study (119 SRI exposed vs 205 SRI unexposed). The median baseline platelet value was 35 × 10 9 /L and 31 × 10 9 /L, respectively. The median platelet nadir was 6 × 10 9 /L, and the median duration of study inclusion was 12 days in both groups. No difference was seen in the incidence of CSB between groups (16% vs 13%, P = 0.487). Hospital length of stay (LOS) (20 vs 19 days, P = 0.227) and intensive care unit (ICU) LOS (3.9 vs 3.9 days, P = 0.996) were similar between groups. On multivariable analysis, SRI exposure was not independently associated with CSB (adjusted odds ratio [aOR] = 1.46, 95% confidence interval [CI] 0.75-2.86). Conclusion and Relevance: In patients with HM and thrombocytopenia, SRI exposure was not associated with an increased risk of CSB. Given the small study size, assessment of patient-specific risks versus benefits should still be considered when prescribing SRI therapy in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaHematologic NeoplasmsHemorrhageSelective Serotonin Reuptake InhibitorsAntidepressive AgentsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultCohort StudiesIncidenceRisk FactorsLength of Stay

Stichwörter der Autor:innen

antidepressive agentshematologic neoplasmshemorrhagethrombocytopenia

Substanzen

Selective Serotonin Reuptake InhibitorsAntidepressive Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Washington University, St. Louis, MO, USA.

ORCID-Profile: Hannah Delp, Emily Gill

Zitieren

APA

Delp, H., Olson, M., Owen, E., McEvoy, C., & Gill, E. (2025). Serotonergic Antidepressant Use and Risk of Clinically Significant Bleeding in Thrombocytopenic Hematologic Malignancy Patients. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251319757

Vancouver

Delp H, Olson M, Owen E, McEvoy C, Gill E. Serotonergic Antidepressant Use and Risk of Clinically Significant Bleeding in Thrombocytopenic Hematologic Malignancy Patients. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251319757

BibTeX
@article{Delp2025,
  author = {Delp, Hannah and Olson, Marissa and Owen, Emily and McEvoy, Colleen and Gill, Emily},
  title = {Serotonergic Antidepressant Use and Risk of Clinically Significant Bleeding in Thrombocytopenic Hematologic Malignancy Patients},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251319757}
}
Kostenlos starten →